Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 results due in 2025. Read more here.
A stye is a lump on your eyelid caused by a bacterial infection. Improperly sanitized contact lens, eye makeup, and conditions like diabetes and rosacea can increase your risk of a stye.